Literature DB >> 1931866

George Lyman Duff Memorial Lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease.

S M Grundy1.   

Abstract

This review underlines the concept that multiple factors are responsible for hypercholesterolemia in the American public. Dietary factors (cholesterol, saturated fatty acids, and obesity) clearly raise the cholesterol level, and they are important causes of borderline-high cholesterol. Still, the unexplained decline of LDL receptor activity with aging contributes importantly to borderline-high levels and cannot be ignored. The loss of estrogen-stimulated LDL receptor synthesis after menopause is an important contributor to elevated cholesterol in postmenopausal women. In addition, several genetic defects inherited singly appear to be responsible for moderate hypercholesterolemia. Some of these defects may represent genetic hypersensitivity to diet, and dietary therapy alone may provide adequate cholesterol lowering. Other defects impart resistance to dietary control, and use of a single cholesterol-lowering drug may be required. With the exception of heterozygous FH, most cases of severe hypercholesterolemia appear to be the result of the coexistence of at least two defects in LDL metabolism, and as a rule, they can be treated successfully only by using cholesterol-lowering drugs in combination.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1931866     DOI: 10.1161/01.atv.11.6.1619

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  14 in total

1.  Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  P W Connelly; D R MacLean; L Horlick; B O'Connor; A Petrasovits; J A Little
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

2.  A novel ARH splice site mutation in a Mexican kindred with autosomal recessive hypercholesterolemia.

Authors:  Samuel Canizales-Quinteros; Carlos A Aguilar-Salinas; Adriana Huertas-Vázquez; María L Ordóñez-Sánchez; Maribel Rodríguez-Torres; José L Venturas-Gallegos; Laura Riba; Salvador Ramírez-Jimenez; Rocío Salas-Montiel; Giovani Medina-Palacios; Ludivina Robles-Osorio; Angel Miliar-García; Luis Rosales-León; Blanca H Ruiz-Ordaz; Alejandro Zentella-Dehesa; Adrian Ferré-D'Amare; Francisco J Gómez-Pérez; Ma Teresa Tusié-Luna
Journal:  Hum Genet       Date:  2004-11-17       Impact factor: 4.132

3.  Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.

Authors:  J Fan; Z S Ji; Y Huang; H de Silva; D Sanan; R W Mahley; T L Innerarity; J M Taylor
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations.

Authors:  J Wang; D J Freeman; S M Grundy; D M Levine; R Guerra; J C Cohen
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

5.  Concentrations of different sterols in the striatum and serum of 3-nitropropionic acid-treated Wistar and Lewis rats.

Authors:  C E Teunissen; M Mulder; J de Vente; K von Bergmann; C De Bruijn; H W Steinbusch; D Lütjohann
Journal:  Neurochem Res       Date:  2001-11       Impact factor: 3.996

Review 6.  Choosing the right lipid-regulating agent. A guide to selection.

Authors:  J A Farmer; A M Gotto
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

7.  A green tea catechin extract upregulates the hepatic low-density lipoprotein receptor in rats.

Authors:  Christina A Bursill; Paul D Roach
Journal:  Lipids       Date:  2007-06-21       Impact factor: 1.880

8.  Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study.

Authors:  F Azizi; M Rahmani; A Ghanbarian; H Emami; P Salehi; P Mirmiran; N Sarbazi
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

9.  LDL receptor expression on T lymphocytes in old patients with Down syndrome.

Authors:  Massimiliano M Corsi; Alexis E Malavazos; Daniele Passoni; Federico Licastro
Journal:  Immun Ageing       Date:  2005-02-10       Impact factor: 6.400

10.  Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells.

Authors:  M R Peluso; J L Dixon
Journal:  Lipids       Date:  1997-08       Impact factor: 1.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.